.
Pulmonology (Pathology Clinical Pharmacology Methods of Examination and Interpretation of Data, Symptomatology and Pharmacotherapy)
Study Course Description
Course Description Statuss:Approved
Course Description Version:4.00
Study Course Accepted:21.03.2024 09:16:46
| Study Course Information | |||||||||
| Course Code: | ISK_050 | LQF level: | Level 7 | ||||||
| Credit Points: | 2.00 | ECTS: | 3.00 | ||||||
| Branch of Science: | Basic Sciences of Medicine, including Pharmacy; Clinical Pharmacy | Target Audience: | Clinical Pharmacy | ||||||
| Study Course Supervisor | |||||||||
| Course Supervisor: | Larisa Umnova | ||||||||
| Study Course Implementer | |||||||||
| Structural Unit: | Department of Internal Diseases | ||||||||
| The Head of Structural Unit: | |||||||||
| Contacts: | Riga, 2 Hipokrata Street, isk rsu[pnkts]lv, +371 67042338 | ||||||||
| Study Course Planning | |||||||||
| Full-Time - Semester No.1 | |||||||||
| Lectures (count) | 7 | Lecture Length (academic hours) | 2 | Total Contact Hours of Lectures | 14 | ||||
| Classes (count) | 5 | Class Length (academic hours) | 2 | Total Contact Hours of Classes | 10 | ||||
| Total Contact Hours | 24 | ||||||||
| Study course description | |||||||||
| Preliminary Knowledge: | Human anatomy, physiology and pathology; medical biochemistry; pharmacology. | ||||||||
| Objective: | To provide students with knowledge in clinical areas – pathophysiology of diseases, clinical manifestations of pulmonary diseases, evaluation of examinations, basic methods of treatment and pharmacotherapy options for respiratory system diseases. The study module comprises an integrated training cycle in which the student is gradually introduced to the pathological physiology of a group of diseases, clinical pharmacology, clinical manifestations, examination possibilities, interpretation of examination data, principles and types of treatment and pharmacotherapy possibilities. | ||||||||
| Topic Layout (Full-Time) | |||||||||
| No. | Topic | Type of Implementation | Number | Venue | |||||
| 1 | Structure and functions of the respiratory system. | Lectures | 1.00 | auditorium | |||||
| 2 | Pathological physiology of the respiratory system. | Lectures | 1.00 | auditorium | |||||
| 3 | Pathologies of the respiratory system. | Classes | 1.00 | auditorium | |||||
| 4 | Clinical pharmacology in pulmonology. | Lectures | 2.00 | auditorium | |||||
| 5 | Pharmacological agents in the treatment of diseases of the respiratory system. | Classes | 2.00 | auditorium | |||||
| 6 | Complaints and anamnesis in patients with respiratory tract diseases. Physical examination of the patient. Methods of examination of the respiratory system. | Lectures | 1.00 | auditorium | |||||
| 7 | Evaluation of the pulmonary ventilation function. Restrictive, obstructive and mixed ventilatory failure, degrees of severity. Interpretation of spirogram data. Bronchoprovocation test. Peak expiratory flow rate measurements, their value. | Lectures | 1.00 | clinical base | |||||
| 8 | Acute pneumonia, causes, classification and pathogenesis thereof. Community-acquired pneumonia, hospital-acquired (nosocomial) and health care-associated acute pneumonia, aspiration pneumonia, pneumonia in immunocompromised patients, congestive pneumonia, infarction pneumonia: causes, risk factors, clinical picture, diagnosis, severity assessment, complications, treatment and indications for hospitalisation. | Lectures | 1.00 | clinical base | |||||
| 9 | Chronic obstructive pulmonary disease (COPD), definition, epidemiology, risk factors, causes, pathogenesis. Clinical picture, course and diagnostic criteria of COPD. Degrees of severity of COPD. Treatment of COPD during remission and exacerbation. | Classes | 1.00 | clinical base | |||||
| 10 | Bronchial asthma: epidemiology, forms, clinical symptoms, examination methods, diagnostic criteria, degrees of severity. Differential diagnosis of bronchial asthma and COPD. Principles of treatment of bronchial asthma. | Classes | 1.00 | clinical base | |||||
| Assessment | |||||||||
| Unaided Work: | The student independently studies the literature offered in the study programme, summarises the obtained information. Prepares a clinical pharmacist’s assessment of pharmacotherapy for a patient with a lung and respiratory system disease. | ||||||||
| Assessment Criteria: | Active participation in practical classes; written assignments completed in high quality and submitted on time, quality of oral answers. Test: understanding of the principles of diagnosis and treatment of internal diseases, including clinical case analysis, is tested. | ||||||||
| Final Examination (Full-Time): | Exam | ||||||||
| Final Examination (Part-Time): | |||||||||
| Learning Outcomes | |||||||||
| Knowledge: | As a result of successfully completing the course, the student will have knowledge of the following: • mechanisms of occurrence of respiratory diseases; • the most common clinical manifestations and complications of respiratory diseases; • methods of examination of diseases of respiratory organs; • basic methods of treatment of respiratory diseases; • principles of medicinal treatment of respiratory diseases. | ||||||||
| Skills: | The student will be able: • to evaluate and interpret the results of respiratory system examinations; • to evaluate medicinal treatment for a patient with lung pathology. | ||||||||
| Competencies: | The student will be able: • in collaboration with the medical practitioners, to determine a pharmacotherapy plan for an individual patient with a lung disease; • to assess the advantages and disadvantages of pharmacotherapy methods in relation to the patient’s examination data; • to monitor the progress of pharmacotherapy, predict side effects and plan the prevention thereof, and provide the necessary information to other medical specialists. | ||||||||
| Bibliography | |||||||||
| No. | Reference | ||||||||
| Required Reading | |||||||||
| 1 | Lekciju un nodarbību materīāli, | ||||||||
| 2 | Bateman E., Hurd S., Barnes P., Bousquet J. et al. Global strategy for asthma management and prevention: GINA executive summary. 2008 (akceptējams izdevums) | ||||||||
| 3 | Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. GOLD Workshop Report. 2005; Update. (akceptējams izdevums) | ||||||||
| 4 | Guidelines for the diagnosis and management of asthma. Focused Updates published in 2020, NHLBI, EPR-3 | ||||||||
| 5 | Kalvelis A. Hroniska obstruktīva plaušu slimība (HOPS informācijas materiāli), 2007 (akceptējams izdevums) | ||||||||
| 6 | Kalvelis A. Pneimonoloģija. Informācijas materiāli, RSU, 2017 | ||||||||
| 7 | A. Lejnieka redakcijā. Klīniskā medicīna. Pirmā grāmata. Rīga, Medicīnas apgāds, 2010 (akceptējams izdevums) | ||||||||
| Additional Reading | |||||||||
| 1 | Goldman-Cecil Medicine. W.B.Saunders Company, Philadelphia, 2020 | ||||||||
| 2 | Siegenthaler W. Differential Diagnosis in Internal medicine: From Symptom to Diagnosis. NY: Thieme Medical Publishers, 2007 | ||||||||
| 3 | The Merck Manual of diagnosis and therapy, edited by Robert S.Porter, 20th ed., 2018 | ||||||||
| Other Information Sources | |||||||||
| 1 | Lynn S. Bickley, Peter G. Szilagyi, B. Bates. Bates' guide to physical examination and history taking. 12th ed. Lippincott Williams & Wilkins, 2017 | ||||||||
| 2 | The Merck Manual, Internets | ||||||||
| 3 | http://www.merck.com/mrkshared/manual/home.jsp | ||||||||
